ArticleOPEN ACCESS

Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease

Alimentary Pharmacology and Therapeutics
DOI: 10.1111/apt.14465
0Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Barclay, M. L., & Stamp, L. K. (2018, February 1). Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease. Alimentary Pharmacology and Therapeutics. Blackwell Publishing Ltd. https://doi.org/10.1111/apt.14465

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free